Skip to main content
ImmuneCited

25-Hydroxyvitamin D supplementation and health-service utilization for upper respiratory tract infection in young children.

Jessica A Omand, Teresa To, Deborah L O'Connor, Patricia C Parkin, Catherine S Birken et al.
Other Public health nutrition 2017 6 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D28578751'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Type d'étude
Cohort Study
Taille de l'échantillon
4962
Population
Children aged 0-5 years in Toronto
Intervention
25-Hydroxyvitamin D supplementation and health-service utilization for upper respiratory tract infection in young children. 25-hydroxyvitamin D supplementation
Comparateur
None
Critère de jugement principal
health service utilization for URTI
Direction de l'effet
Neutral
Risque de biais
Low

Abstract

OBJECTIVE: Upper respiratory tract infections (URTI) are the most common and costly condition of childhood. Low vitamin D levels have been hypothesized as a risk factor for URTI. The primary objective was to determine if serum vitamin D levels were associated with health-service utilization (HSU) for URTI including hospital admission, emergency department visits and outpatient sick visits. The secondary objectives were to determine whether oral vitamin D supplementation in pregnancy or childhood was associated with HSU for URTI. DESIGN: Cohort study. HSU was determined by linking each child's provincial health insurance number to health administrative databases. Multivariable quasi Poisson regression was used to evaluate the association between 25-hydroxyvitamin D, vitamin D supplementation and HSU for URTI. SETTING: Toronto, Canada. SUBJECTS: Children participating in the TARGet Kids! network between 2008 and 2013. RESULTS: Healthy children aged 0-5 years (n 4962) were included; 52 % were male and mean 25-hydroxyvitamin D was 84 nmol/l (range 11-355 nmol/l). There were 105 (2 %), 721 (15 %) and 3218 (65 %) children with at least one hospital admission, emergency department visit or outpatient sick visit for URTI, respectively. There were no statistically significant associations between 25-hydroxyvitamin D or vitamin D supplementation and HSU for URTI. CONCLUSIONS: A clinically meaningful association between vitamin D (continuously and dichotomized at <50 and <75 nmol/l) and HSU for URTI was not identified. While vitamin D may have other benefits for health, reducing HSU for URTI does not appear to be one of them.

En bref

A clinically meaningful association between vitamin D (continuously and dichotomized at <50 and <75 nmol/l) and HSU for URTI was not identified and vitamin D may have other benefits for health, but reducing Hsu for U RTI does not appear to be one of them.

Used In Evidence Reviews

Similar Papers